(Fig. 6A,B) In contrast, the number of SM α-actin/Ki67-double positive SMCs was significantly increased in leiomyoma tissues treated with GnRHa treatment compared with those not treated with GnRHa, (Fig. 6C,D), which resulted in the development of solid uterine myomas. This evidence concerns the gene MKI67 and leiomyoma.